Here is the Question of the Day:
A bankruptcy judge has conditionally approved a settlement in the suit against Oxy-Contin maker Purdue Pharma in a deal that left many unhappy. If approved, the Sackler family would pay $4.5 billion and give up ownership of the company, and that money plus company profits would be put toward treatment and education programs. How should Delaware use funds it may receive in the settlement to help those with opioid addiction?
Join the conversation below and see what others have to say! You can sign in to World Table with your existing Google, Twitter, Facebook, or Disqus account, or create a new account. And remember, we may use comments from this feature on the newspaper’s Opinion page or in stories we are preparing, so keep it civil.